Search Results - "Shatin, D."

Refine Results
  1. 1

    Heart failure among younger rheumatoid arthritis and Crohn's patients exposed to TNF-α antagonists by Curtis, J. R., Kramer, J. M., Martin, C., Saag, K. G., Patkar, N., Shatin, D., Burgess, M., Xie, A., Braun, M. M.

    Published in Rheumatology (Oxford, England) (01-11-2007)
    “…Objectives. New onset heart failure (HF) has been associated with the use of TNF-α antagonists etanercept and infliximab based upon spontaneous adverse event…”
    Get full text
    Journal Article
  2. 2

    Tramadol and Seizures: A Surveillance Study in a Managed Care Population by Gardner, Jacqueline S., Blough, David, Drinkard, Carol R., Shatin, Deborah, Anderson, Gail, Graham, David, Alderfer, Raymond

    Published in Pharmacotherapy (01-12-2000)
    “…Study Objective. To investigate the occurrence of tramadol‐associated seizures. Design. Retrospective cohort and case‐control studies. Setting. UnitedHealth…”
    Get full text
    Journal Article
  3. 3

    Impact of mailed warning to prescribers on the co-prescription of tramadol and antidepressants by Shatin, Deborah, Gardner, Jacqueline S., Stergachis, Andy, Blough, David, Graham, David

    Published in Pharmacoepidemiology and drug safety (01-03-2005)
    “…Purpose An evaluation was made of the effectiveness in changing prescribing behavior of ‘Dear Health Professional (DHP)’ letters mailed by the manufacturer to…”
    Get full text
    Journal Article
  4. 4

    Health Care Utilization by Children With Chronic Illnesses: A Comparison of Medicaid and Employer-insured Managed Care by Shatin, Deborah, Levin, Regina, Ireys, Henry T, Haller, Virginia

    Published in Pediatrics (Evanston) (01-10-1998)
    “…Objectives. This study compared utilization of health care services by children with chronic conditions who were insured by either Medicaid or an employer…”
    Get full text
    Journal Article
  5. 5

    Mobility impairments and use of preventive services in women with multiple sclerosis: observational study by Cheng, Eric, Myers, Lawrence, Wolf, Sheldon, Shatin, Deborah, Cui, Xin-Ping, Ellison, George, Belin, Thomas, Vickrey, Barbara

    Published in BMJ (27-10-2001)
    “…47We collected self reported rates of cervical smear testing, mammography, and breast examination (if over age 50), blood pressure checks, cholesterol…”
    Get full text
    Journal Article
  6. 6

    Postmarketing surveillance of medications and pregnancy outcomes: Clarithromycin and birth malformations by Drinkard, Carol R., Shatin, Deborah, Clouse, Jon

    Published in Pharmacoepidemiology and drug safety (01-12-2000)
    “…Purpose This retrospective surveillance study used linked administrative claims data and medical records to determine the rate and types of birth malformations…”
    Get full text
    Journal Article
  7. 7

    Heart failure among younger rheumatoid arthritis and Crohn's patients exposed to TNF-  antagonists by Curtis, J. R., Kramer, J. M., Martin, C., Saag, K. G., Patkar, N., Shatin, D., Burgess, M., Xie, A., Braun, M. M.

    Published in Rheumatology (Oxford, England) (01-11-2007)
    “…Objectives. New onset heart failure (HF) has been associated with the use of TNF-α antagonists etanercept and infliximab based upon spontaneous adverse event…”
    Get full text
    Journal Article
  8. 8

    Management of multiple sclerosis across managed care and fee-for-service systems by VICKREY, B. G, SHATIN, D, ELLISON, G. W, WOLF, S. M, MYERS, L. W, BELIN, T. R, HANSON, R. A, SHAPIRO, M. F, BECKSTRAND, M, EDMONDS, Z. V, DELRAHIM, S

    Published in Neurology (14-11-2000)
    “…To measure and compare care for adults with MS across managed care and fee-for-service (FFS) health systems. The authors sampled adults with MS having…”
    Get full text
    Journal Article
  9. 9
  10. 10

    General neurologist and subspecialist care for multiple sclerosis : Patients' perceptions by VICKREY, B. G, EDMONDS, Z. V, SHATIN, D, SHAPIRO, M. F, DELRAHIM, S, BELIN, T. R, ELLISON, G. W, MYERS, L. W

    Published in Neurology (12-10-1999)
    “…To compare general neurologists and MS specialists on patients' clinical characteristics and MS care as perceived by patients with MS. We sampled all adult…”
    Get full text
    Journal Article
  11. 11

    Incidence of Hospitalized Rhabdomyolysis in Patients Treated With Lipid-Lowering Drugs by Graham, David J, Staffa, Judy A, Shatin, Deborah, Andrade, Susan E, Schech, Stephanie D, La Grenade, Lois, Gurwitz, Jerry H, Chan, K. Arnold, Goodman, Michael J, Platt, Richard

    “…CONTEXT Lipid-lowering agents are widely prescribed in the United States. Reliable estimates of rhabdomyolysis risk with various lipid-lowering agents are not…”
    Get full text
    Journal Article
  12. 12
  13. 13

    Diabetes mellitus in managed care: complications and resource utilization

    Published in The American journal of managed care (01-05-2001)
    “…To implement a diabetes mellitus surveillance system designed to use administrative data and to demonstrate how it can be used by managed care organizations…”
    Get full text
    Journal Article
  14. 14

    Healthy pregnancy program in a national managed care organization: evaluation of satisfaction and health behavior outcomes by Drinkard, C R, Shatin, D, Luo, D, Heinen, M J, Hawkins, M M, Harmon, R G

    Published in The American journal of managed care (01-04-2001)
    “…To evaluate satisfaction with the Healthy Pregnancy Program (HPP), which was developed to educate and coordinate the care of pregnant women in a managed care…”
    Get full text
    Journal Article
  15. 15

    Use of services by diabetes patients in managed care organizations. Development of a diabetes surveillance system. CDC Diabetes in Managed Care Work Group by Engelgau, M M, Geiss, L S, Manninen, D L, Orians, C E, Wagner, E H, Friedman, N M, Hurley, J S, Trinkaus, K M, Shatin, D, Van Vorst, K A

    Published in Diabetes care (01-12-1998)
    “…Use of services by diabetes patients in managed care organizations. Development of a diabetes surveillance system. CDC Diabetes in Managed Care Work Group. M M…”
    Get full text
    Journal Article
  16. 16

    Contraindicated Use of Cisapride: Impact of Food and Drug Administration Regulatory Action by Smalley, Walter, Shatin, Deborah, Wysowski, Diane K, Gurwitz, Jerry, Andrade, Susan E, Goodman, Michael, Chan, K. Arnold, Platt, Richard, Schech, Stephanie D, Ray, Wayne A

    “…CONTEXT Cisapride, a gastrointestinal tract promotility agent, can cause life-threatening cardiac arrhythmias in patients susceptible either because of…”
    Get full text
    Journal Article
  17. 17

    Incidence of Idiopathic Acute Liver Failure and Hospitalized Liver Injury in Patients Treated With Troglitazone by Graham, David J, Drinkard, Carol R, Shatin, Deborah

    Published in The American journal of gastroenterology (01-01-2003)
    “…Troglitazone, a thiazolidinedione antidiabetic agent, was withdrawn from the U.S. market in March, 2000, after 94 cases of acute liver failure (ALF) were…”
    Get full text
    Journal Article
  18. 18

    Totally implantable spinal cord stimulation for chronic pain: design and efficacy by Shatin, D, Mullett, K, Hults, G

    Published in Pacing and clinical electrophysiology (01-07-1986)
    “…Neurostimulators used to treat chronic, intractable pain have evolved from technical developments in pacemaker technology. A totally implantable spinal cord…”
    Get more information
    Journal Article
  19. 19

    Adverse events associated with prolonged antibiotic use by Meropol, Sharon B., Chan, K. Arnold, Chen, Zhen, Finkelstein, Jonathan A., Hennessy, Sean, Lautenbach, Ebbing, Platt, Richard, Schech, Stephanie D., Shatin, Deborah, Metlay, Joshua P.

    Published in Pharmacoepidemiology and drug safety (01-05-2008)
    “…Purpose The Infectious Diseases Society of America and US CDC recommend 60 days of ciprofloxacin, doxycycline, or amoxicillin for anthrax prophylaxis. It is…”
    Get full text
    Journal Article
  20. 20

    Liver Enzyme Monitoring in Patients Treated With Troglitazone by Graham, David J, Drinkard, Carol R, Shatin, Deborah, Tsong, Yi, Burgess, Margaret J

    “…CONTEXT Soon after initial marketing in March 1997, troglitazone, the first thiazolidinedione antidiabetic agent, was found to cause life-threatening acute…”
    Get full text
    Journal Article